Maximum allowable blood loss (MABL) estimates how much blood a patient can lose during surgery before their hematocrit falls to a clinician-chosen floor. It is a planning tool used alongside — never in place of — real-time clinical assessment during a procedure.
How MABL is calculated
MABL = EBV × (Hi − Hf) / Hi, where EBV is the patient's estimated blood volume, Hi is their initial hematocrit, and Hf is the minimum acceptable hematocrit chosen for that patient. The formula assumes blood is lost and not replaced during the interval being estimated — as blood volume is lost, red cell mass falls proportionally, and the hematocrit declines toward Hf.
EBV itself is often estimated using Nadler's formula from height, weight, and sex when a direct measurement is not available, using separate regression coefficients for males and females.
Choosing the minimum acceptable hematocrit
There is no single universal cutoff for Hf. A commonly cited general reference range is 21–24% for otherwise healthy patients, but the appropriate floor depends on age, cardiopulmonary reserve, ongoing bleeding risk, and the specific procedure. Clinicians typically choose a higher (more conservative) Hf for patients with limited cardiac reserve, and may accept a lower Hf in healthy patients with good compensatory capacity.
Limits and how to use the result
MABL is a planning estimate, not a real-time monitor. It does not account for ongoing fluid resuscitation, third-spacing, dilutional effects from crystalloid administration, or a patient's evolving hemodynamic status during a procedure. It is intended to help anticipate, before or during surgery, roughly how much blood loss margin exists — the actual decision to transfuse remains an individualized clinical judgment based on the complete clinical picture, not a fixed number.